IMM Immupharma Plc

 

TIDMIMM 
 
RNS Number : 3926N 
Immupharma PLC 
10 June 2010 
 

+------------------------------+------------------------------+ 
| For Immediate Release        |                 10 June 2010 | 
+------------------------------+------------------------------+ 
 
 
                                 ImmuPharma PLC 
 
                           Annual Report and Accounts 
                Notice of Annual General Meeting : 17 June 2010 
 
 
In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the 
specialist drug discovery and development company, confirms that the Annual 
Report and Accounts for the year ended 31 December 2009, has been posted to 
shareholders. 
 
The annual report is available, in electronic form, for download on the 
Company's website www.immupharma.com. 
 
The Company's Annual General Meeting will be held on 17 June 2010 at 11am at 50 
Broadway, London, SW1H 0BL. 
 
-     Ends  - 
 
 
 
For further information please contact: 
 
+------------------------------+------------------------------+ 
| ImmuPharma PLC:              |                              | 
+------------------------------+------------------------------+ 
| Dimitri Dimitriou, Chief     |             +44 20 7152 4080 | 
| Executive Officer            |                              | 
+------------------------------+------------------------------+ 
| Richard Warr, Chairman       |             +44 20 7152 4080 | 
+------------------------------+------------------------------+ 
|                              |                              | 
+------------------------------+------------------------------+ 
| Buchanan Communications      |            + 44 20 7466 5000 | 
+------------------------------+------------------------------+ 
| Lisa Baderoon                |          www.buchanan.uk.com | 
+------------------------------+------------------------------+ 
| Catherine Breen              |                              | 
+------------------------------+------------------------------+ 
| George Prassas               |                              | 
+------------------------------+------------------------------+ 
|                              |                              | 
+------------------------------+------------------------------+ 
| Panmure Gordon & Co          |                              | 
+------------------------------+------------------------------+ 
| Andrew Burnett               |             +44 151 243 0963 | 
+------------------------------+------------------------------+ 
| Rakesh Sharma                |                              | 
+------------------------------+------------------------------+ 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 ACSFMMLTMBABMIM 
 

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024